135 related articles for article (PubMed ID: 1535593)
1. Pharmacokinetics and dialysability of isradipine in chronic haemodialysis patients.
Schönholzer K; Marone C
Eur J Clin Pharmacol; 1992; 42(2):231-3. PubMed ID: 1535593
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of amlodipine in hypertensive patients undergoing haemodialysis.
Kungys G; Naujoks H; Wanner C
Eur J Clin Pharmacol; 2003 Aug; 59(4):291-5. PubMed ID: 12845505
[TBL] [Abstract][Full Text] [Related]
3. Effect of diltiazem on the pharmacokinetics of MPC-1304, a new calcium channel blocker.
Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Shiga T; Ebihara A
Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):271-4. PubMed ID: 1526689
[TBL] [Abstract][Full Text] [Related]
4. Enantioselective determination of lercanidipine in human plasma for pharmacokinetic studies by normal-phase liquid chromatography-tandem mass spectrometry.
Jabor VA; Coelho EB; Ifa DR; Bonato PS; dos Santos NA; Lanchote VL
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):429-37. PubMed ID: 14581082
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of oral isradipine in normal volunteers.
Clifton GD; Blouin RA; Dilea C; Schran HF; Hassell AE; Gonasun LM; Foster TS
J Clin Pharmacol; 1988 Jan; 28(1):36-42. PubMed ID: 2965165
[TBL] [Abstract][Full Text] [Related]
6. A study of plasma disposition kinetics of lacidipine after single oral ascending doses.
Squassante L; Caveggion E; Braggio S; Pellegatti M; Baroldi P
J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S94-7. PubMed ID: 7609516
[TBL] [Abstract][Full Text] [Related]
7. Initial experience with isradipine for the treatment of hypertension in children.
Strauser LM; Groshong T; Tobias JD
South Med J; 2000 Mar; 93(3):287-93. PubMed ID: 10728516
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of nisoldipine in renal dysfunction.
Boelaert J; Valcke Y; Dammekens H; De Vriese G; Ahr G; Schurgers M; Daneels R; Bogaert MG
Eur J Clin Pharmacol; 1988; 34(2):207-9. PubMed ID: 3383992
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function.
Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ
Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451
[TBL] [Abstract][Full Text] [Related]
10. Isradipine dynamics and pharmacokinetics in the isolated rabbit heart.
Mellemkjaer S; Bang L; Nielsen-Kudsk F
Pharmacol Toxicol; 1992 May; 70(5 Pt 1):366-72. PubMed ID: 1535129
[TBL] [Abstract][Full Text] [Related]
11. The pharmokinetics of isradipine in hypertensive subjects.
Shenfield GM; Boutagy J; Stokes GS; Rumble F; Dunagan F
Eur J Clin Pharmacol; 1990; 38(2):209-11. PubMed ID: 2140098
[TBL] [Abstract][Full Text] [Related]
12. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP
Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222
[TBL] [Abstract][Full Text] [Related]
13. Absorption, plasma concentration, and excretion after single administration of 14C-(+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats and dogs.
Matsunaga T; Tanabe H; Mochizuki T; Okabe K; Arizono H; Taneda M; Sato H; Ishii S; Sato J; Kiyoki M
Arzneimittelforschung; 1992 Apr; 42(4):519-25. PubMed ID: 1642676
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacokinetic and pharmacodynamic effects of isradipine in patients with arterial hypertension].
Svetyĭ LI; Alekhin SN
Eksp Klin Farmakol; 2002; 65(5):35-8. PubMed ID: 12596512
[TBL] [Abstract][Full Text] [Related]
15. Clinical hypotension with co-prescription of macrolide antibiotics and calcium-channel blockers in haemodialysis patients: a retrospective chart review.
Hiremath S; Ruzicka M; Nagaraju SP; McCormick BB
Drug Saf; 2013 Oct; 36(10):989-93. PubMed ID: 23873482
[TBL] [Abstract][Full Text] [Related]
16. Single dose pharmacokinetics of manidipine in hepatic impaired patients and healthy controls.
Deroubaix X; Lins RL; Lens S; Allemon A; Jeanbaptiste B; Poli G; Acerbi D; Stockis A; Ventura P
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):386-91. PubMed ID: 9707354
[TBL] [Abstract][Full Text] [Related]
17. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
Salomone S; Godfraind T
Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.
Endresen L; Bergan S; Holdaas H; Pran T; Sinding-Larsen B; Berg KJ
Ther Drug Monit; 1991 Nov; 13(6):490-5. PubMed ID: 1837629
[TBL] [Abstract][Full Text] [Related]
19. Isradipine--another calcium-channel blocker for the treatment of hypertension and angina.
Lopez LM; Santiago TM
Ann Pharmacother; 1992 Jun; 26(6):789-99. PubMed ID: 1535246
[TBL] [Abstract][Full Text] [Related]
20. In vivo specific binding characteristics and pharmacokinetics of a 1,4-dihydropyridine calcium channel antagonist in the senescent mouse brain.
Uchida S; Yamada S; Deguchi Y; Yamamoto M; Kimura R
Pharm Res; 2000 Jul; 17(7):844-50. PubMed ID: 10990204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
